Eads & Heald Wealth Management Organon & Co. Transaction History

Eads & Heald Wealth Management

  • $203 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024
BUY
$18.65 - $23.03 $6,340 - $7,830
340 Added 3.26%
10,760 $206,000
Q2 2024

Jul 23, 2024
BUY
$17.45 - $21.96 $181,829 - $228,823
10,420 New
10,420 $215,000
Q1 2023

Apr 21, 2023
BUY
$21.42 - $32.08 $189,138 - $283,266
8,830 New
8,830 $208,000

Others Institutions Holding OGN

# of Institutions
797
Shares Held
202M
Call Options Held
1.45M
Put Options Held
870K
View Full List

About Organon & Co.

OGN Quotes by TradingView
  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.83B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Eads & Heald Wealth Management Portfolio

Follow Eads & Heald Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eads & Heald Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Eads & Heald Wealth Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email